Is a COVID-19 Vaccine Likely to Make Things Worse?

In order to limit the disease burden and economic costs associated with the COVID-19 pandemic, it is important to understand how effective and widely distributed a vaccine must be in order to have a beneficial impact on public health. To evaluate the potential effect of a vaccine, we developed risk...

Full description

Bibliographic Details
Main Authors: Stéphanie M. C. Abo, Stacey R. Smith?
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/8/4/761
Description
Summary:In order to limit the disease burden and economic costs associated with the COVID-19 pandemic, it is important to understand how effective and widely distributed a vaccine must be in order to have a beneficial impact on public health. To evaluate the potential effect of a vaccine, we developed risk equations for the daily risk of COVID-19 infection both currently and after a vaccine becomes available. Our risk equations account for the basic transmission probability of COVID-19 (<inline-formula><math display="inline"><semantics><mi>β</mi></semantics></math></inline-formula>) and the lowered risk due to various protection options: physical distancing; face coverings such as masks, goggles, face shields or other medical equipment; handwashing; and vaccination. We found that the outcome depends significantly on the degree of vaccine uptake: if uptake is higher than 80%, then the daily risk can be cut by 50% or more. However, if less than 40% of people get vaccinated and other protection options are abandoned—as may well happen in the wake of a COVID-19 vaccine—then introducing even an excellent vaccine will produce a worse outcome than our current situation. It is thus critical that effective education strategies are employed in tandem with vaccine rollout.
ISSN:2076-393X